Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-28 @ 6:25 AM
Study NCT ID:
NCT05817435
Status:
COMPLETED
Last Update Posted:
2023-10-31
First Post:
2023-04-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-05
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-30
Last Update Post Date:
2023-10-31
Last Update Post Date Type:
ACTUAL